methyl (1S,2S,3S,4R)-3-[(1R)-1-amino-2-ethylbutyl]-2-hydroxy-4-[(2-methylpropan-2-yl)oxycarbonylamino]cyclopentane-1-carboxylate
98%
- Product Code: 36260
CAS:
316173-29-2
| Molecular Weight: | 358.47 g./mol | Molecular Formula: | C₁₈H₃₄N₂O₅ |
|---|---|---|---|
| EC Number: | MDL Number: | ||
| Melting Point: | Boiling Point: | ||
| Density: | Storage Condition: | room temperature, dry |
Product Description:
This compound is primarily utilized in the pharmaceutical industry as an intermediate in the synthesis of complex drug molecules. Its unique stereochemistry and functional groups make it a valuable building block for the development of protease inhibitors, particularly those targeting viral enzymes. The presence of both amino and ester groups allows for further chemical modifications, enabling the creation of potent therapeutic agents. Additionally, its cyclopentane structure contributes to the stability and bioavailability of the final drug product, making it a critical component in the production of antiviral medications.
Product Specification:
| Test | Specification |
|---|---|
| PURITY | 97.5-100 |
| Infrared spectrum | Conforms to Structure |
Sizes / Availability / Pricing:
| Size (g) | Availability | Price | Quantity |
|---|---|---|---|
| 1.000 | 10-20 days | ฿2,260.00 |
+
-
|
| 5.000 | 10-20 days | ฿9,980.00 |
+
-
|
| 25.000 | 10-20 days | ฿35,200.00 |
+
-
|
methyl (1S,2S,3S,4R)-3-[(1R)-1-amino-2-ethylbutyl]-2-hydroxy-4-[(2-methylpropan-2-yl)oxycarbonylamino]cyclopentane-1-carboxylate
This compound is primarily utilized in the pharmaceutical industry as an intermediate in the synthesis of complex drug molecules. Its unique stereochemistry and functional groups make it a valuable building block for the development of protease inhibitors, particularly those targeting viral enzymes. The presence of both amino and ester groups allows for further chemical modifications, enabling the creation of potent therapeutic agents. Additionally, its cyclopentane structure contributes to the stability and bioavailability of the final drug product, making it a critical component in the production of antiviral medications.
| Mechanism | - |
| Appearance | - |
| Longevity | - |
| Strength | - |
| Storage | - |
| Shelf Life | - |
| Allergen(s) | - |
| Dosage (Range) | - |
| Recommended Dosage | - |
| Dosage (Per Day) | - |
| Recommended Dosage (Per Day) | - |
| Mix Method | - |
| Heat Resistance | - |
| Stable in pH range | - |
| Solubility | - |
| Product Types | - |
| INCI | - |
Cart
No products
Subtotal:
฿0.00
฿0.00
Total :